# Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.

> **NCT04806412** · NA · UNKNOWN · sponsor: **Naestved Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Malignant Pleural Effusion
- Non-small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** meassurement of PD-L1, ALK, EGFR

## Key facts

- **NCT ID:** NCT04806412
- **Lead sponsor:** Naestved Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-15
- **Primary completion:** 2023-03-12
- **Final completion:** 2023-05-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04806412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04806412, "Oncodrivers in Malignant Pleural Effusions Associated With Non-small Cell Lung Cancer: A Prospective Study.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04806412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*